Dissociation between 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission

Dissociation between 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission

Abstract Background Inflammation of patients joints with severe disease activity of rheumatoid arthritis (RA) has already been visualized and quantified by 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography ([18F] FDG PET/CT), but little is known about the metabolic status and its...

Full description

Bibliographic Details
Main Authors: Charline Rinkin, Pacôme Fosse, Olivier Malaise, Nathalie Chapelier, Jil Horrion, Laurence Seidel, Adelin Albert, Roland Hustinx, Michel G. Malaise
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Rheumatology
Subjects:
Positron emission tomography (PET)
Remission
Rheumatoid arthritis (RA)
Ultrasonography (US)
Online Access:https://doi.org/10.1186/s41927-021-00196-1

Internet

https://doi.org/10.1186/s41927-021-00196-1

Similar Items